The international limits and population at risk of Plasmodium vivax transmission in 2009
Background A research priority for Plasmodium vivax malaria is to improve our understanding of the spatial distribution of risk and its relationship with the burden of P. vivax disease in human populations. The aim of the research outlined in this article is to provide a contemporary evidence-based...
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
Public Library of Science
2010
|
| _version_ | 1826258049943207936 |
|---|---|
| author | Guerra, C Howes, R Patil, A Gething, P Van Boeckel, T Temperley, W Kabaria, C Tatem, A Manh, B Elyazar, I Baird, J Snow, R Hay, S |
| author_facet | Guerra, C Howes, R Patil, A Gething, P Van Boeckel, T Temperley, W Kabaria, C Tatem, A Manh, B Elyazar, I Baird, J Snow, R Hay, S |
| author_sort | Guerra, C |
| collection | OXFORD |
| description | Background A research priority for Plasmodium vivax malaria is to improve our understanding of the spatial distribution of risk and its relationship with the burden of P. vivax disease in human populations. The aim of the research outlined in this article is to provide a contemporary evidence-based map of the global spatial extent of P. vivax malaria, together with estimates of the human population at risk (PAR) of any level of transmission in 2009. Methodology The most recent P. vivax case-reporting data that could be obtained for all malaria endemic countries were used to classify risk into three classes: malaria free, unstable (<0.1 case per 1,000 people per annum (p.a.)) and stable (≥0.1 case per 1,000 p.a.) P. vivax malaria transmission. Risk areas were further constrained using temperature and aridity data based upon their relationship with parasite and vector bionomics. Medical intelligence was used to refine the spatial extent of risk in specific areas where transmission was reported to be absent (e.g., large urban areas and malaria-free islands). The PAR under each level of transmission was then derived by combining the categorical risk map with a high resolution population surface adjusted to 2009. The exclusion of large Duffy negative populations in Africa from the PAR totals was achieved using independent modelling of the gene frequency of this genetic trait. It was estimated that 2.85 billion people were exposed to some risk of P. vivax transmission in 2009, with 57.1% of them living in areas of unstable transmission. The vast majority (2.59 billion, 91.0%) were located in Central and South East (CSE) Asia, whilst the remainder were located in America (0.16 billion, 5.5%) and in the Africa+ region (0.10 billion, 3.5%). Despite evidence of ubiquitous risk of P. vivax infection in Africa, the very high prevalence of Duffy negativity throughout Central and West Africa reduced the PAR estimates substantially. Conclusions After more than a century of development and control, P. vivax remains more widely distributed than P. falciparum and is a potential cause of morbidity and mortality amongst the 2.85 billion people living at risk of infection, the majority of whom are in the tropical belt of CSE Asia. The probability of infection is reduced massively across Africa by the frequency of the Duffy negative trait, but transmission does occur on the continent and is a concern for Duffy positive locals and travellers. The final map provides the spatial limits on which the endemicity of P. vivax transmission can be mapped to support future cartographic-based burden estimations. |
| first_indexed | 2024-03-06T18:27:53Z |
| format | Journal article |
| id | oxford-uuid:089d677d-591d-4da1-bdea-8f0fb7300ff4 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:27:53Z |
| publishDate | 2010 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:089d677d-591d-4da1-bdea-8f0fb7300ff42022-03-26T09:13:48ZThe international limits and population at risk of Plasmodium vivax transmission in 2009Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:089d677d-591d-4da1-bdea-8f0fb7300ff4EnglishSymplectic Elements at OxfordPublic Library of Science2010Guerra, CHowes, RPatil, AGething, PVan Boeckel, TTemperley, WKabaria, CTatem, AManh, BElyazar, IBaird, JSnow, RHay, SBackground A research priority for Plasmodium vivax malaria is to improve our understanding of the spatial distribution of risk and its relationship with the burden of P. vivax disease in human populations. The aim of the research outlined in this article is to provide a contemporary evidence-based map of the global spatial extent of P. vivax malaria, together with estimates of the human population at risk (PAR) of any level of transmission in 2009. Methodology The most recent P. vivax case-reporting data that could be obtained for all malaria endemic countries were used to classify risk into three classes: malaria free, unstable (<0.1 case per 1,000 people per annum (p.a.)) and stable (≥0.1 case per 1,000 p.a.) P. vivax malaria transmission. Risk areas were further constrained using temperature and aridity data based upon their relationship with parasite and vector bionomics. Medical intelligence was used to refine the spatial extent of risk in specific areas where transmission was reported to be absent (e.g., large urban areas and malaria-free islands). The PAR under each level of transmission was then derived by combining the categorical risk map with a high resolution population surface adjusted to 2009. The exclusion of large Duffy negative populations in Africa from the PAR totals was achieved using independent modelling of the gene frequency of this genetic trait. It was estimated that 2.85 billion people were exposed to some risk of P. vivax transmission in 2009, with 57.1% of them living in areas of unstable transmission. The vast majority (2.59 billion, 91.0%) were located in Central and South East (CSE) Asia, whilst the remainder were located in America (0.16 billion, 5.5%) and in the Africa+ region (0.10 billion, 3.5%). Despite evidence of ubiquitous risk of P. vivax infection in Africa, the very high prevalence of Duffy negativity throughout Central and West Africa reduced the PAR estimates substantially. Conclusions After more than a century of development and control, P. vivax remains more widely distributed than P. falciparum and is a potential cause of morbidity and mortality amongst the 2.85 billion people living at risk of infection, the majority of whom are in the tropical belt of CSE Asia. The probability of infection is reduced massively across Africa by the frequency of the Duffy negative trait, but transmission does occur on the continent and is a concern for Duffy positive locals and travellers. The final map provides the spatial limits on which the endemicity of P. vivax transmission can be mapped to support future cartographic-based burden estimations. |
| spellingShingle | Guerra, C Howes, R Patil, A Gething, P Van Boeckel, T Temperley, W Kabaria, C Tatem, A Manh, B Elyazar, I Baird, J Snow, R Hay, S The international limits and population at risk of Plasmodium vivax transmission in 2009 |
| title | The international limits and population at risk of Plasmodium vivax transmission in 2009 |
| title_full | The international limits and population at risk of Plasmodium vivax transmission in 2009 |
| title_fullStr | The international limits and population at risk of Plasmodium vivax transmission in 2009 |
| title_full_unstemmed | The international limits and population at risk of Plasmodium vivax transmission in 2009 |
| title_short | The international limits and population at risk of Plasmodium vivax transmission in 2009 |
| title_sort | international limits and population at risk of plasmodium vivax transmission in 2009 |
| work_keys_str_mv | AT guerrac theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT howesr theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT patila theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT gethingp theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT vanboeckelt theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT temperleyw theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT kabariac theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT tatema theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT manhb theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT elyazari theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT bairdj theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT snowr theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT hays theinternationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT guerrac internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT howesr internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT patila internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT gethingp internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT vanboeckelt internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT temperleyw internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT kabariac internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT tatema internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT manhb internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT elyazari internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT bairdj internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT snowr internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 AT hays internationallimitsandpopulationatriskofplasmodiumvivaxtransmissionin2009 |